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A B S T R A C T   
Adult kidney stem cells are known to have important roles in renal regeneration after acute kidney injury. 
Although trophic factors from tissue stem cells have been reported to promote the regeneration of other organs, 
there is limited number of evidence of this phenomenon in the kidneys. Here, we explored the effects of secreted 
factors from kidney stem cells. We intraperitoneally administered culture supernatant obtained from adult rat 
kidney stem/progenitor cells into rat kidney ischemia/reperfusion injury models, and the treatment significantly 
ameliorated renal tubulointerstitial injury, suppressed tubular cell apoptosis, diminished inflammation and 
promoted the proliferation of both residual renal cells and immature cells. In vitro, treatment with culture su-
pernatant from kidney stem cells significantly promoted cell proliferation and suppressed cisplatin-induced cell 
apoptosis in both normal rat kidney cells and kidney stem cells. In addition, treatment with culture supernatant 
increased the expression of nestin in normal rat kidney cells, suggesting the dedifferentiation of tubular cells into 
stem-like cells. Analysis of the culture supernatant revealed that it contained a variety of growth factors. Taken 
together, the results suggest that these factors together lead to renal regeneration. In conclusion, adult kidney 
stem cells contribute to renal regeneration indirectly through the secretion of regenerative factors.   
1. Introduction 
Acute kidney injury (AKI) is a major healthcare problem associated 
with prolonged hospitalization and high mortality rates (DuBose et al., 
1997; Thadhani et al., 1996). Ischemic renal injury is one of the 
common causes of AKI (Aydin et al., 2007; Kazmers et al., 1997; 
Mangano et al., 1998). Despite advances in medical technology, there 
are no better options for treating AKI than supportive treatments, such 
as renal replacement therapy (DuBose et al., 1997). On the other hand, 
the recovery of renal function after AKI is sometimes observed. Im-
provements in renal function require the recovery of injured renal tu-
bules and the regeneration of these tubules. Although it is controversial 
which cell type can reconstruct damaged tubules and promote tubular 
regeneration, three candidate cell types, residual tubular cells, bone 
marrow-derived stem cells and kidney stem cells, have been reported. 
For example, previous reports have revealed that surviving tubular cells 
around injured tubules dedifferentiate and replace lost tubular cells 
(Humphreys et al., 2008; Kusaba et al., 2014). Others have demon-
strated that bone marrow-derived cells promote regeneration via the 
replacement of lost tubular cells (Iwasaki et al., 2005; Kale et al., 2003). 
More recently, Lazzeri et al. demonstrated progenitor-driven renal re-
generation after AKI that can be pharmacologically enhanced (Lazzeri 
et al., 2018). Taken together, the repair system involved in renal re-
generation after kidney injury might be complex and several cell types, 
including residual tubular cells, bone marrow-derived stem cells and 
kidney stem cells, might contribute to the regeneration together. 
As a regenerative treatment, mesenchyme stem cell (MSC) therapy 
has been reported to be effective in different models of kidney diseases 
(Asanuma et al., 2010; Bi et al., 2007; Herrera et al., 2004; Kunter et al., 
2007; Morigi et al., 2008; Togel et al., 2009, 2005) through the direct 
differentiation of stem/progenitor cells into renal mature cells. How-
ever, recent evidence suggests that both the number of stem cells that 
undergo direct differentiation into mature tubular cells and the rate of 
this process are limited (Humphreys et al., 2008; Lange et al., 2005; 
Togel et al., 2005; Vogetseder et al., 2008). Instead, other reports have 
revealed that MSC therapy protects residual cells via trophic factors 
secreted from MSCs (Bi et al., 2007; Caplan and Dennis, 2006; Gnecchi 
et al., 2005; Rabb, 2005; Tang et al., 2005; Togel et al., 2005). These 
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findings indicate a strong potential of stem cells for mediating tissue 
regeneration indirectly via trophic factors. 
Regarding kidney stem cells, several research groups revealed the 
presence of adult renal stem/progenitor cells using different kinds of 
technologies. (Maeshima et al., 2014) (Bussolati and Camussi, 2015; 
Tsuji and Kitamura, 2015). For example, Inowa et al. identified kidney 
side population (SP) cells using Hoechst 33,342 staining and indicated 
that the SP cell population in human kidney is 1.3% (Inowa et al., 
2008). Dekel et al. isolated adult kidney stem/progenitor cells as stem 
cell antigen-1 (sca-1)-positive cells (Dekel et al., 2006). Gupta et al. 
isolated multipotent renal progenitor cells (MRPC) using specific cell 
culture conditions (Gupta et al., 2006) and reported that injection of 
MRPC differentiated into renal tubules. Maeshima et al. also identified 
adult kidney stem/progenitor cells using DNA labeling with BrdU and 
named the cells slow cycling label-retaining cells (LRCs) (Maeshima 
et al., 2003). In addition, several groups identified CD133(+)CD24(+) 
adult kidney stem cells in Bowman’s capsule, inner medullary papilla, 
and proximal tubular cells (Bussolati et al., 2005; Lindgren et al., 2011; 
Sagrinati et al., 2006; Sallustio et al., 2013, 2010). Although these re-
ports suggest the regenerative potential of adult kidney stem/pro-
genitor cells under renal injury, the contribution of these stem cells to 
regeneration is still controversial and unclear. 
Our group previously established an adult rat renal stem/pro-
genitor-like cell line (KS cells) from the S3 segment of the renal prox-
imal tubules of adult rat kidneys (Kitamura et al., 2005). KS cells have 
stem cell-like characteristics, including self-renewal ability, prolonged 
cell proliferation and regenerative ability. When we injected LacZ-la-
beled KS cells into cisplatin-induced AKI rats at the subcapsule of the 
left kidney, the treatment with KS cells implantation improved renal 
function, induced cell proliferation, and limited tubulointerstitial injury 
and tubular cell apoptosis (Kinomura et al., 2008; Kitamura et al., 
2005). In addition, Bluo-gal(+) KS cells with AQP1 expression were 
observed in the corticomedullary junction. Although there is a con-
troversy of the capacity of differentiation of the stem cells into mature 
cells, the result suggested that implanted KS cells migrate to injured 
tubules and then differentiate into mature renal cells (Kinomura et al., 
2008; Kitamura et al., 2005). Interestingly, adjacent tubular epithelial 
cells of Bluo-gal(+) KS cells expressed AQP1 more intensely than KS 
cells, and the amelioration of tubular cell apoptosis and tubular injury 
was also observed in the right kidney without KS cell implantation. 
Taken together with the fact that the number of Bluo-gal(+) KS cells in 
the corticomedullary junction are limited, we hypothesized that there 
might be an indirect regenerative pathway that involves the secretion of 
trophic factors from kidney stem/progenitor cells during renal re-
generation. Here, we examined the effect of the culture supernatant of 
KS cells in rat models of kidney ischemia/reperfusion (I/R) and in vitro. 
2. Material and methods 
2.1. Animal experimental design 
The experimental protocol was approved by the Animal Ethics 
Review Committee of the Okayama University Graduate School of 
Medicine, Dentistry and Pharmaceutical Sciences (OKU-2012106 and 
OKU-2018579). Studies were performed on 5-week-old male Sprague- 
Dawley rats obtained from CLEA (CLEA Japan, Tokyo, JAPAN). The 
animals had free access to tap water and standard rat chow. 
2.2. Cell culture 
KS cells were isolated from adult rat kidneys as previously reported 
(Kitamura et al., 2005). KS cells were cultured in a 1:1 mixture of 
culture supernatant of mouse MCSs [Dulbecco’s modified Eagle medium 
(DMEM; Sigma, St. Louis, MO) containing 10% fetal calf serum (FCS; 
Gibco, Grand Island, NY)] and modified K1 medium [1:1 mixture of 
DMEM and Ham’s F12 medium (Gibco), supplemented with 10% FCS, 
5 μg/ml insulin, 2.75 μg/ml transferrin, 3.35 ng/ml sodium selenium 
acid (ITS-X, Gibco), 50 nM hydrocortisone (Sigma), 25 ng/ml hepato-
cyte growth factor (HGF, Sigma), 2.5 mM nicotinamide (Sigma)], pe-
nicillin G (100 U/ml) and streptomycin (100 μg/ml) on type IV col-
lagen-coated disks or 75 cm2 flasks (BD Bioscience, San Jose, CA). NRK- 
52E cells were cultured in DMEM and Ham’s F12 culture medium 
containing 10% FCS and penicillin G (100 U/ml) and streptomycin 
(100 μg/ml). 
2.3. Collection of cell culture supernatant 
Concentrated supernatant of KS cells (CS-KS) and concentrated su-
pernatant of NRK-52E cells (CS-NRK) were generated using the fol-
lowing protocol for in vivo and in vitro experiments. KS cells on type IV 
collagen coated 75 cm2 flasks and NRK-52E cells on 75 cm2 flasks were 
cultured until they were subconfluent and were washed with phos-
phate-buffered saline (PBS; Gibco). Then, the cells were incubated with 
20 ml of mixed medium (DMEM/F12, Gibco) without serum for 24 h. 
The supernatant was harvested, and the cellular debris was removed 
using MediaKap-2 filters (Spectrum Laboratories, Inc.). The supernatant 
was concentrated (40×) using Amicon Ultra-15 Centrifugal Filter Units 
with Ultracel-3 membranes (Millipore) according to the manufacturer’s 
instructions. For control vehicle, 20 ml of medium (DMEM/F12, Gibco) 
was concentrated (40×) using Amicon Ultra-15 Centrifugal Filter Units 
with Ultracel-3 membranes. 
2.4. Induction of acute kidney injury by ischemia-reperfusion and treatment 
with cell supernatant 
Kidney ischemia/reperfusion (I/R) injury was induced in rats by 
clamping the left renal artery for 45 min and then removing the right 
kidney. Because some rats did not show the reperfusion even after the 
clamp removal most likely due to renal artery thrombus, we only chose 
rats with good perfusion for the experiment and separated these rats 
into four groups: the sham-operated group (sham group, n = 6), vehicle 
treatment group (I/R plus intraperitoneal administration of 500 μl of 
vehicle 3 h after I/R; I/R group, n = 7), KS cell supernatant treatment 
group (I/R plus intraperitoneal administration of 500 μl of CS-KS 3 h 
after I/R; I/R-CS-KS group, n = 6), and CS-NRK treatment group (I/R 
plus intraperitoneal administration of 500 μl of CS-NRK 3 h after I/R; I/ 
R-CS-NRK group, n = 5). At the end of each experimental period, 24- 
hour urine samples were collected. The rats were sacrificed 2 days after 
I/R, and the kidney tissues were obtained for paraffin embedding or 
frozen sectioning. Blood samples were drawn from the vena cava in-
ferior while the rats were under anesthesia. The levels of serum crea-
tinine (S-Cr), blood urea nitrogen (BUN), urinary creatinine (U-Cr) and 
urinary N-acetyl-β-D-glucosaminidase (U-NAG) were measured by 
Oriental Yeast CO., LTD. (Tokyo, Japan). We also conducted an ex-
periment in which rats from 3 groups, namely, the sham group (n = 6), 
I/R group (n = 5), and I/R-CS-KS group (n = 6), were sacrificed 4 days 
after I/R. 
2.5. Histological examination 
Collected kidney tissues were fixed in 10% buffered formalin and 
were embedded in paraffin. Sections (4 μm thick) were stained with 
hematoxylin and eosin (H&E) for light microscopy observation. Tubular 
damage was scored by calculation of the percentage of tubules in the 
corticomedullary area that displayed cell necrosis, loss of brush border, 
tubular dilation, and cast formation: 0, none; 1, < 10%; 2, 10%–25%; 
3, 26%–45%; 4, 46%–75%; 5, > 76%. 10 high-power fields (200×) per 
section for each samples were examined (n = 3–6). 
2.6. Immunohistochemical staining 
Frozen kidney sections were subjected to cryosectioning (4 μm) and 
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immunofluorescence staining with primary antibody [rabbit polyclonal 
anti-histone H3 p-Ser10 (Millipore, Darmstadt, Germany), mouse 
monoclonal anti-nestin (R&D Systems, MN, USA), guinea pig polyclonal 
anti-nephrin (PROGEN Biotechnil GmbH, Heidelberg, Germany), rat 
monoclonal anti-F4/80 (Abcam) antibody, hepatocyte growth factor 
(HGF) (Institute of Immunology, Tokyo, Japan), epidermal growth 
factor (EGF) (Institute of Immunology), transforming growth factor-β 
(TGF-β) (Bio Vision, Milpitas, CA, USA), and erythropoietin (Epo) 
(Santa Cruz, CA, USA)] overnight at 4 °C after incubation with 1% 
bovine serum albumin (BSA) in PBS. After three washes with PBS, the 
sections were incubated with secondary antibody conjugated to FITC 
(sheep IgG; Chemicon, Temecula, CA, USA) or rhodamine (goat IgG; 
Chemicon) for 1 h at room temperature. The sections were washed and 
counterstained with 4′,6′-diamidino-2-phenylindole (DAPI; Roche 
Diagnostics GmbH, Mannheim, Germany). The number of histone H3 p- 
Ser10-positive and HGF-positive cells in 10 randomly selected fields in 
each kidney section was counted at 200× magnification. Nestin-posi-
tive area was evaluated in 10 randomly selected fields at 200× mag-
nification in each kidney section using the ImageJ software. The F4/80 
positive area in 5 randomly selected fields from each section was 
evaluated at 200× magnification using ImageJ software. 
KS cells and NRK-52E cells were plated on chamber slides (16 well, 
ThermoFisher Scientific), allowed to grow to 90% confluence. Then, 
0.05 μg/ml cisplatin with or without 10 μl of CS-KS or CS-NRK was 
added to the NRK-52E cells. After 24 h, the cells were fixed with 4% 
paraformaldehyde (PFA) in PBS for 20 min, and then permeabilized 
with 0.01% Triton X-100 in PBS for 4 min. After incubation with 1% 
BSA in PBS, the cells were incubated with primary antibody (HGF, EGF, 
and Epo antibody) overnight at 4 °C. The cells were washed with PBS 
three times and then incubated with a secondary antibody conjugated 
to FITC or rhodamine for 1 h at room temperature. The sections were 
washed and counterstained with DAPI. Images were captured using an 
FSX100 microscope (Olympus Corporation, Tokyo, Japan). 
2.7. TUNEL staining 
Degrees of tubular apoptosis were assessed using in situ DNA nick 
end labeling (TUNEL) technique. Paraffin-embedded sections (4 μm 
thick) were processed for immunohistochemistry using the DeadEnd 
fluorometric TUNEL system (Promega) according to the manufacturer’s 
instructions and were counterstained with DAPI (Roche Diagnostics 
GmbH). The number of TUNEL-positive cells in the outer stripe of the 
outer medulla in 10 randomly selected fields was counted at 200× 
magnification in each kidney section. 
2.8. In vitro assay using electric cell-substrate impedance sensing 
For the investigation of real-time cell behavior, we applied the 
electric cell-substrate impedance sensing (ECIS) method (Applied 
Biophysics, Troy, NY, USA). 1.0 × 104 KS cells were placed in each well 
of an 8W10E + ECIS array (Applied Biophysics) and cultured with 
400 μl of medium with or without 10 μl of KS supernatant (n = 3, each) 
containing cisplatin (0.05 μg/ml) on type IV collagen (BD Bioscience)- 
coated dishes. We collected resistance, impedance, and capacitance 
data every 90 s. The measurement of cell adhesion was based on the 
changes in the ratio of resistance/capacitance to the current flow ap-
plied to the electrode arrays at different frequencies (Heijink et al., 
2010). A frequency scan was performed to determine the frequency at 
which the greatest difference in Rep was obtained between the cell- 
covered and cell-free electrodes. The baseline was established using 
culture medium (400 μl / well) alone and was compared with values 
obtained using electrodes covered with a monolayer of cells in 400 μl of 
medium. 
2.9. Immunoblot analysis 
SDS-PAGE and immunoblot analysis were performed as described 
previously (Rabb, 2005). Protein concentration was calculated using a 
modified Lowry Protein Assay Kit (Thermo Scientific) and we loaded 
20 μg protein of CS-KS and KS cells lysate for each lane. Primary rabbit 
antibodies against HGF (1000× dilution), bone morphogenetic protein- 
7 (BMP-7, 1000× dilution) (AVIVA systems biology, San Diego, CA, 
USA), EGF (1000× dilution), TGF-β (1000× dilution), Epo (1000× 
dilution), and vascular endothelial growth factor (VEGF, 1000× dilu-
tion) (Abcam, Cambridge, MA) were used. Secondary anti-rabbit IgG 
antibodies (10,000× dilution) conjugated to horseradish peroxidase 
(BIO-RAD) were used. The images were developed using the ECL plus 
western blotting detection system (GE Healthcare). The bands were 
detected using ImageQuant LAS 4000 mini (GE Healthcare) and were 
evaluated using the ImageJ software. 
2.10. Statistical analysis 
Statistical analysis was performed by JMP (SAS Institute Inc. version 
11.0.0 for Windows software). Statistical significance was defined by one- 
way analysis of variance (ANOVA) with the post-hoc Turkey’s test. Data are 
shown as the mean  ±  SE. Significance was defined as p  <  0.05. 
3. Results 
3.1. Culture supernatant from adult rat kidney stem cells ameliorates 
tubulointerstitial injury 
SD rats were subjected to I/R injury and we examined the re-
generative effect of culture supernatant from KS cells. Histological 
analysis by hematoxylin and eosin (H&E) staining showed renal tubular 
injury, including renal tubular necrosis, cast formation, loss of brush 
border and dilatation in the cortico-medullary junction area, in the rats 
that underwent I/R injury compared to the sham group (Fig. 1A). The 
damage was extensive in the I/R group and I/R-CS-NRK groups com-
pared to the I/R-CS-KS group on day 2. Analysis by tissue injury scores 
revealed that the damage was significantly lower in the I/R-CS-KS 
group than in the I/R and I/R-CS-NRK groups on day 2 (Fig. 1B), in-
dicating that CS-KS treatment ameliorates tubulointerstitial injury and 
that CS-NRK does not have this effect. Tissue damage was also lower in 
the I/R-CS-KS group compared to the I/R group on day 4 (Fig. 1B). 
Next, we examined the renal function. BUN and S-Cr levels were sig-
nificantly elevated in the rats that underwent I/R injury compared to 
the sham group on day 2 (Fig. 1, C and D). Importantly, S-Cr and BUN 
levels in the I/R-CS-KS group were significantly lower than those in the 
I/R group on day 2 (Fig. 1C and D). In addition, U-NAG levels were 
significantly lower in the I/R-CS-KS group compared to the I/R group 
2 days after I/R (Fig. 1E), suggesting that CS-KS treatment attenuates 
renal tubulointerstitial injury. 
3.2. Culture supernatant from adult rat kidney stem cells inhibits apoptosis 
and induces proliferation of tubular epithelial cells 
Tubular apoptosis was evaluated by counting the number of TUNEL- 
positive cells in the I/R and I/R-CS-KS groups. On day 2, the number of 
TUNEL-positive renal tubular cells was significantly lower in the I/R- 
CS-KS group compared to the I/R group (Fig. 2A), indicating that CS-KS 
treatment protects against tubular cell apoptosis. 
Cell proliferation is indispensable for the regeneration and repair of 
injured renal tubules. Cell proliferation within the tubules was eval-
uated by immunohistochemical staining for a mitosis marker, histone 
H3 p-Ser10. The number of histone H3 p-Ser10-positive cells was sig-
nificantly higher in the I/R-CS-KS group compared to the I/R group on 
day 2 and 4 (Fig. 2B), indicating that CS-KS treatment promotes tubular 
cell proliferation after I/R injury. 
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Fig. 1. Culture supernatant of adult kidney stem/progenitor cells attenuates renal function and tubular injury in an I/R model. (A) Tubulointerstitial alterations were 
examined by hematoxylin and eosin (H&E) staining in the sham-operated group (sham group), the group that underwent rat kidney ischemia-reperfusion (I/R) plus 
intraperitoneal administration of vehicle (I/R group), the group that underwent I/R plus intraperitoneal administration of CS-KS (I/R-CS-KS group), and the group 
that underwent I/R plus intraperitoneal administration of CS-NRK (I/R-CS-NRK group). Representative images on day 2 after kidney I/R are shown. Scale bars, 
200 μm in upper panels; 50 μm in middle panels; 20 μm in lower panels. (B–E) Tissue injury scores (B), serum creatinine (S-Cr) (C), blood urea nitrogen (BUN) (D), 
and urinary NAG (U-NAG) (E) levels in the sham group, I/R group, I/R-CS-KS group and I/R-CS-NRK group were measured on day 2 and 4. D2; day2, D4; day4. **: 
P  <  0.01; *: P  <  0.05. 
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3.3. Culture supernatant from adult rat kidney stem cells attenuates renal 
tubulointerstitial inflammation and promotes immature renal cell 
proliferation 
We evaluated renal tubulointerstitial inflammation. The area posi-
tive for F4/80, a marker of macrophage infiltration, was smaller in the 
I/R-CS-KS group than in the I/R group on day 4 (Fig. 3A and B), sug-
gesting that CS-KS has the potential to attenuate renal tubulointerstitial 
inflammation in I/R injury. 
A previous report revealed an increase in stem/progenitor cells, 
which promote renal regeneration, in rodent AKI models. Nestin has 
been reported to be a stem cell marker (Chen et al., 2006). Therefore, 
we evaluated the number of nestin-positive immature cells in the I/R 
model. A significant increase in the nestin-positive area was observed in 
the I/R-CS-KS group compared to the I/R group on day 4 (Fig. 3A and 
C), indicating that CS-KS has the potential to activate immature cell 
proliferation and/or dedifferentiation of residual tubular cells in an I/R 
model. 
3.4. Adult rat kidney stem cells secrete growth factors 
These results strongly suggest that CS-KS contains trophic factors 
that protect against kidney injury. Some kinds of growth factors have 
been reported to ameliorate kidney injuries. Therefore, we examined 
the expression of several growth factors, such as HGF, BMP-7, EGF, 
TGF-β, EPO and VEGF, which have been reported to be regenerative 
factors (Hammerman and Miller, 1994; Kang et al., 2001; Luo et al., 
2005; Miller et al., 1994; Mohamed et al., 2013; Zeisberg et al., 2003). 
Immunoblot analysis revealed that CS-KS contained HGF, EGF, TGF-β 
and Epo (Fig. 4A). The expression of HGF, EGF, Epo in KS cells were 
also confirmed by immunostaining (Fig. 4B). These factors might play 
important roles in the regeneration process during renal injury. 
We also analyzed growth factor expression in the sham, I/R, and I/ 
R-CS-KS groups by immunofluorescence staining. While no different 
expression pattern was observed in EGF staining among these groups, 
increased Epo and TGFβ1 expressions were observed in the I/R and I/R- 
CS-KS groups compared to the sham group on day 2 (Supplementary 
Fig. 1), most likely due to renal ischemia caused by I/R injury. In ad-
dition, increased HGF expression was observed in the rats that under-
went I/R injury compared to the sham group (Fig. 4C). Interestingly, 
the number of HGF-positive cells was higher in the I/R-CS-KS group 
compared to the I/R group (Fig. 4C). These results suggested that CS-KS 
might affect the secretomes of HGF from tubular cells or kidney stem 
cells. 
3.5. Culture supernatant from adult rat kidney stem cells protects against 
cisplatin-induced cell injury and promotes the dedifferentiation of renal cells 
in vitro 
To further confirm the trophic effect of CS-KS, immunofluorescence 
analyses were carried out to further evaluate the effect of CS-KS. 
Treating NRK-52E cells with CS-KS significantly increased the number 
of histone H3 p-Ser10-positive cells (Fig. 5A–C and G), indicating that 
CS-KS promotes mature cell proliferation. Interestingly, treating NRK- 
52E cells with CS-KS significantly increased the number of Nestin-po-
sitive cells (Fig. 5D–F and H), suggesting that CS-KS might lead to the 
transition of mature cells to immature cells, or dedifferentiation, which 
has been reported to play important roles during renal regeneration 
Fig. 2. Culture supernatant of adult kidney stem/progenitor cells attenuates renal cell apoptosis and activates renal cell proliferation in an I/R model. (A) Renal cell 
apoptosis in the group that underwent rat kidney ischemia-reperfusion (I/R) plus intraperitoneal administration on vehicle (I/R group) and the group that underwent 
I/R plus intraperitoneal administration of CS-KS (I/R-CS-KS group) was evaluated by Terminal deoxynucleotidyl transferase–mediated digoxigenin-deoxyuridine 
nick-end labeling (TUNEL) staining (green) with DAPI staining (blue) on day 2. Scale bars, 50 μm in upper panels; 25 μm in lower panels. The graph shows the 
number of tubular TUNEL-positive cells/200 × field measured on day 2. (B) Anti-histone H3 p-Ser10 staining (red) with nephrin (green) and DAPI staining (blue) 
was performed on day 2 and 4 in the sham, I/R and I/R-CS-KS groups. Scale bars, 25 μm in left panels; 250 μm in middle panels; 50 μm in right panels. The graph 
shows the number of tubular histone H3 p-Ser10-positive cells/200×-field measured on day 2 and 4. **: P  <  0.01. 
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(Kusaba et al., 2014). 
To examine the autocrine effect of KS cells, we examined the effect 
of CS-KS in vitro by monitoring cell behavior after cisplatin-induced cell 
injury in real time using the ECIS method. In this system, high re-
sistance indicates increased strength of intracellular junctions and 
connection strength between cells and their scaffolds, and low capaci-
tance indicates active cell proliferation. KS cells were cultured in the 
presence of 0.05 μg/ml cisplatin with or without 10 μl of CS-KS. CS-KS 
treatment elevated the resistance and decreased the capacitance more 
rapidly than the control (no treatment) or CS-NRK treatment (Fig. 6A 
and B), suggesting that CS-KS might promote KS cell proliferation and 
attenuate cisplatin-induced KS cell apoptosis. Taken together, the re-
sults suggested that adult kidney stem cells might work in both an 
paracrine and autocrine manner to promote renal regeneration. 
4. Discussion 
Treatment with stem cells has been reported to be beneficial in 
various kidney disorders. However, the protective mechanisms of these 
stem cells are still controversial. Several reports have suggested the 
involvement of different mechanisms, including the direct differentia-
tion of stem/progenitor cells and the protection of residual cells by 
regenerative growth factors secreted from stem cells (Tsuji and 
Kitamura, 2015). We previously reported that implanted adult kidney 
stem/progenitor cells, which directly contribute to renal regeneration. 
Tögel et al. reported that the paracrine effect is primarily responsible 
for the organ-protective actions of administered mesenchymal stem 
cells (Togel et al., 2005). Bi et al. reported that conditioned medium 
from bone marrow mesenchymal stem cells (BMSCs) decreases tubular 
cell apoptosis, increases the survival time of animals and limits renal 
injury (Bi et al., 2007). Along this line, MSCs have been reported to 
secrete a variety of factors, such as HGF, insulin-like growth factor-1 
(IGF-1), EGF, VEGF, prostaglandin E2 (PGE2), granulocyte colony-sti-
mulating factor (G-CSF) and macrophage colony-stimulating factor 
(M−CSF) (Aggarwal and Pittenger, 2005; Caplan and Dennis, 2006; 
Groh et al., 2005; Togel et al., 2005). Moreover, the injection of HGF 
and IGF-1 has been reported to reduce renal tubular injury (Miller et al., 
1992; Miller et al., 1994). Taken together, the evidence suggests that 
trophic factors from stem cells promote renal regeneration after injury. 
In the present study, we focused on factors secreted by adult kidney 
stem/progenitor cells and revealed that these cells produce a variety of 
trophic factors, that lead to renal regeneration by promoting cell pro-
liferation and inhibiting renal cell apoptosis both in vivo and in vitro. 
Interestingly, the trophic mechanisms of renal repair were similar to 
Fig. 3. Culture supernatant of adult kidney stem/progenitor cells attenuates renal inflammation and activates immature cell activity. (A) F4/80 (red) and nestin 
(green) staining with DAPI staining (blue) was performed in the sham-operated group (sham group), the group that underwent rat kidney ischemia-reperfusion (I/R) 
plus intraperitoneal administration on vehicle (I/R group) and the group that underwent I/R plus intraperitoneal administration of CS-KS (I/R-CS-KS group) on day 4. 
Scale bars, 25 μm in upper panels; 10 μm in lower panels. (B) The F4/80-positive area/200 × field was determined on day 4. (C) The nestin-positive area/200 × field 
was determined on day 4. **: P  <  0.01. 
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those previously reported to underlie the effects of the injection of KS 
cells themselves. Based on these results together with the previous re-
port that the number of implanted KS cells that directly differentiated 
into mature cells was limited, we conclude that the indirect therapeutic 
mechanism involved in renal regeneration induced by trophic factors 
from KS cells might be the major contributor to renal repair under KS 
cell therapy. Importantly, we also suggest that the dedifferentiation of 
residual tubular cells might occur via trophic factors. Kusaba et al. 
previously reported that tubular epithelial cells contribute to renal re-
pair through dedifferentiation and replacement with stem cell markers 
(Kusaba et al., 2014). Taken together, these findings suggest that renal 
stem/progenitor cells promote this process through the secretion of 
trophic factors. 
Sallustio et al. previously reported that CD133(+) human renal 
stem/progenitor cells repair tubular injury through TLR2-driven in-
hibin-A and microvesicle-shuttled decorin (Sallustio et al., 2013). Ag-
garwal et al. reported that human CD133(+) renal progenitor cells 
limit renal fibrosis after tubular injury through the secretion of ery-
thropoietin (Aggarwal et al., 2016). More recently, Ranghino et al. re-
ported that CD133(+) cells, but not extracellular vesicles from 
CD133(+) cells, contribute to renal regeneration after ischemia/re-
perfusion renal injury (Ranghino et al., 2017). These CD133(+) 
progenitor cells lack six2 expression (Brossa et al., 2018), while KS cells 
have high six2 expression, indicating a difference in the characteristics 
of CD133(+) progenitor cells and KS cells. Indeed, CS-KS treatment 
might activate tubular cell dedifferentiation, which was not reported 
with CD133(+) cell treatment. 
We injected the 40× concentrated culture supernatant of KS cells in 
vivo based on the fact that the injected supernatant would be diluted by 
absorption in the intraperitoneal cavity before ultimately reaching the 
injured kidney. Our study revealed indirect regenerative effects of 
trophic factors from adult kidney stem/progenitor cells, which were 
evaluated based on improvements in tubular injury markers and renal 
function. We assumed that adult kidney stem/progenitor cells in the S3 
segment proliferate and secrete trophic factors in both a paracrine and 
autocrine manner and that these processes promote renal regeneration 
and attenuate renal injury during or after kidney injury, including I/R 
injury. Therefore, it is important to further explore how adult kidney 
stem/progenitor cells in the S3 segment are activated during kidney 
injury and how we can promote stem cell-mediated renal regeneration. 
Adult kidney stem/progenitor cells secrete a variety of trophic fac-
tors, which make it difficult to identify the main factor that contributes 
to the promotion of regeneration. Based on these results showing some 
of the therapeutic mechanisms of CS-KS, including anti-inflammation, 
Fig. 4. Trophic factors in the culture supernatant of adult kidney stem/progenitor cells. (A) HGF, BMP-7, EGF, TGF-β, Epo, and VEGF expression in CS-KS and KS cells 
was analyzed by immunoblot analysis. 20 µg of the protein lysate was loaded in each lane. (B) Immunofluorescence staining for HGF, EGF and Epo in KS cells. Scale 
bars, 25 μm. (C) HGF (green) staining with DAPI staining (blue) was performed in the sham-operated group (sham group), the group that underwent rat kidney 
ischemia-reperfusion (I/R) plus intraperitoneal administration on vehicle (I/R group) and the group that underwent I/R plus intraperitoneal administration of CS-KS 
(I/R-CS-KS group) on day 2. Scale bars, 50 μm. The graph shows the HGF-positive cells/200 × field determined on day 2. **: P  <  0.01. 
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anti-apoptosis, and proliferation, several secreted factors from adult 
kidney stem/progenitor cells likely affect the regeneration of residual 
renal cells and immature cells together (Fig. 7). Importantly, the factors 
secreted from NRK-52E cells do not have regenerative effects, in-
dicating that adult kidney stem/progenitor cells specifically indirectly 
contribute to regeneration. Interestingly, the number of HGF-positive 
cells was higher in the I/R-CS-KS group compared to the I/R group, 
suggesting that trophic factors from kidney stem cells might affect the 
secretomes from cells in the kidney. It was difficult to distinguish which 
cells produce HGF after CS-KS treatment, but it might be the adult 
stem/progenitor cells stimulated by CS-KS or dedifferentiated tubular 
cells by CS-KS. 
Recent reports have revealed that stem cells secrete extracellular 
vesicles containing mRNA, protein and micro RNAs, which have im-
portant roles in cell–cell communication, in addition to trophic pro-
teins, including growth factors. These factors have been reported to 
have essential roles during tissue injury and regeneration (Tsuji and 
Kitamura, 2015). For example, a recent report revealed that adult 
kidney stem/progenitor cells have the potential to secrete microvesicles 
that contain protective mRNAs (Orlic et al., 2003). CS-KS might contain 
exosomes, which might be regenerative factors. Recent studies have 
revealed that exosomes from MSCs attenuate renal injury (Bruno et al., 
Fig. 5. Effects of culture supernatant of adult kidney stem/progenitor cells on NRK-52E cells. Anti-histone H3 p-Ser10 staining (red) or anti-Nestin staining (green) 
with DAPI staining (blue) was performed on NRK-52E cells treated with 0.05 μg/ml cisplatin (cisplatin, A; red, D; green), NRK-52E cells treated with 0.05 μg/ml 
cisplatin containing 10 μl of KS supernatant (cisplatin + CS-KS; red, B; green, E), and NRK-52E cells treated with 0.05 μg/ml cisplatin containing 10 μl of CS-NRK 
(cisplatin + CS-NRK; red, C; green, F). Scale bars, 50 μm in each panels. The ratios of histone H3 p-Ser10-positive cells (G) and nestin-positive cells/DAPI-positive 
area (H) were analyzed. CS-KS treatment resulted in a significant increase in the number of histone H3 p-Ser10-positive cells and nestin-positive area. The number of 
histone H3 p-Ser10-positive cells was determined in 5 randomly selected fields from each section at 200× magnification. The area of nestin-positive area was 
evaluated in 5 randomly selected fields at 200× magnification in each section. **: P  <  0.01. 
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2012, 2009; Gatti et al., 2011; He et al., 2012; Zhou et al., 2013). The 
exploration of exosomes in CS-KS might have the potential to open the 
new therapies for renal regeneration. 
There are several limitations to be discussed in the study. First, CS- 
KS was injected only once (3 h after I/R injury) in vivo. Because the 
supply of trophic factors from stem/progenitor cells might be con-
tinuous during the regenerative period under physiological conditions, 
we need to keep in mind that there might be differences in both the 
concentration of these factors and the timing of trophic factor supply 
between intraperitoneal treatment and physiological conditions during 
renal regeneration. Second, we only focused on the acute phase of renal 
regeneration in this experiments, since we evaluated the renal tissue in 
2 time points of day 2 and day 4. Although we elucidated that CS-KS 
treatment promoted regeneration through a variety of different me-
chanisms, including promotion of proliferation and de-differentiation, 
and inhibition of cell apoptosis and renal interstitial inflammation, 
further analysis is required for elucidating how long these trophic fac-
tors can maintain regenerative effects and whether CS-KS can protect 
from renal injury in the chronic stage. 
5. Conclusions 
Adult kidney stem/progenitor cells contribute to renal regeneration 
through the secretion of protective factors. 
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Fig. 7. Therapeutic mechanism of the effects of cul-
ture supernatant from adult kidney stem/progenitor 
cells against I/R injury. Rat kidney ischemia-re-
perfusion injury (I/R) causes tubulointerstitial in-
flammation and tubular cell apoptosis. Trophic fac-
tors from adult kidney stem/progenitor cells promote 
renal regeneration in both paracrine and autocrine 
manner. These mechanisms include the attenuation 
of tubular cell apoptosis and renal inflammation as 
well as the activation of immature cell proliferation 
and residual tubular cell proliferation partly via 
tubular cell dedifferentiation. 
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